A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Clinical trial NCT07520162 · RECRUITING

Trial details

NCT number: NCT07520162
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Rhinosinusitis With Nasal Polyps

Start date: 2026-04-24
Primary completion: 2028-03-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.